Tarrytown, NY, United States of America

Andres Perez Bay

This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andres Perez Bay. Retrieved from https://idiyas.com/inventor/andres-perez-bay-aumcja8w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andres Perez Bay

Introduction

Andres Perez Bay is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. His work focuses on creating molecules that can effectively target specific antigens, which is crucial in the treatment of various diseases.

Latest Patents

One of his key patents is titled "Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof." This patent highlights his innovative approach to targeting HER2, a protein that can promote the growth of cancer cells. The patent showcases his expertise in designing molecules that can bind to multiple targets, enhancing the efficacy of treatments.

Career Highlights

Andres Perez Bay is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its cutting-edge research and development. His role at Regeneron allows him to collaborate with other experts in the field, further advancing the development of novel therapies.

Collaborations

Due to space constraints, the details of his collaborations will not be included.

Conclusion

Andres Perez Bay's contributions to the field of biotechnology, particularly through his patent on bispecific antigen binding molecules, demonstrate his commitment to advancing medical science. His work at Regeneron Pharmaceuticals, Inc. positions him as a key player in the development of innovative therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…